Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNp73alpha protects myogenic cells from apoptosis.

L Belloni1, F Moretti, P Merlo

  • 1Fondazione A Cesalpino and Department of Internal Medicine, University of Rome La Sapienza, Rome, Italy.

Oncogene
|May 3, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of the molecular tumor board: learnings from the ROME trial.

NPJ precision oncology·2026
Same author

Unlocking personalized endometrial cancer treatment: the critical role of the BBIRE biobank in sample collection and distribution.

Frontiers in molecular biosciences·2026
Same author

Editorial Expression of Concern: USP2a alters chemotherapeutic response by modulating redox.

Cell death & disease·2026
Same author

Effective and safe use of alirocumab in spinal and bulbar muscular atrophy with high cardiovascular risk: a case report.

European review for medical and pharmacological sciences·2025
Same author

Establishment of a replacement batch for the Ph. Eur. Heparin low-molecular-mass for calibration CRS.

Pharmeuropa bio & scientific notes·2025
Same author

Effectiveness of Biologic Therapy in Hidradenitis Suppurativa: Real-World Clinical Outcomes and Lipid Profile Evaluation.

The Australasian journal of dermatology·2025

Dominant-negative p73 (DNp73) isoforms are crucial for skeletal muscle regeneration. DNp73 protects differentiating muscle cells from apoptosis and confers resistance to DNA damage, highlighting its therapeutic potential.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Developmental Biology

Background:

  • The p73 gene generates multiple isoforms, including transactivation-competent (TAp73) and dominant-negative (DNp73) forms.
  • TAp73 proteins regulate cell cycle arrest and apoptosis in response to DNA damage and are vital for development.
  • DNp73 proteins inhibit p53 and p73 transcription, exhibiting anti-apoptotic and pro-proliferative effects.

Purpose of the Study:

  • To investigate the role of DNp73alpha during myogenic differentiation of C2C12 skeletal muscle satellite cells.
  • To elucidate the regulatory mechanisms of the P2p73 promoter during muscle differentiation.
  • To determine the impact of DNp73 on apoptosis and DNA damage resistance in differentiating muscle cells.

Main Methods:

  • Analysis of P73 gene transcription and promoter activity (P1 and P2) during C2C12 cell differentiation.

Related Experiment Videos

  • Expression analysis of DNp73alpha in proliferating myoblasts, differentiating myocytes, and myotubes.
  • Chromatin immunoprecipitation and transactivation assays to study promoter regulation.
  • siRNA-mediated knockdown of DNp73 to assess its role in apoptosis.
  • Comparison of TAp73 and DNp73 roles in DNA damage response.

    • Main Results:

    • DNp73alpha expression increases during C2C12 cell differentiation and remains elevated in myotubes.
    • MyoD and p53/p73 coordinate the upregulation of the P2p73 promoter during myogenic differentiation.
    • DNp73 knockdown potentiates spontaneous apoptosis in differentiating C2C12 cells.
    • Endogenous DNp73 confers resistance to DNA damage in differentiated myotubes, contrasting with TAp73's pro-apoptotic role.

    Conclusions:

    • DNp73alpha plays a critical role in regulating apoptosis during skeletal muscle differentiation.
    • DNp73alpha mediates the resistance of differentiated myotubes to DNA damage.
    • DNp73alpha is a potential therapeutic target for enhancing skeletal muscle regeneration.